Friday, 23 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDeals

XRGenesis Raises $14 Million in Series A to Advance Ophthalmic Surgical Technology

October 30, 2024
CompanyDrug

Taiwan FDA Reviews Nefecon New Drug Application from Everest Medicines

October 30, 2024
CompanyDeals

J&J’s Janssen Secures Exclusive Global Rights to Develop LCB84 ADC from LegoChem Biosciences

October 30, 2024
CompanyDeals

BMS Expands Oncology Portfolio with $4.1 Billion RayzeBio Acquisition

November 13, 2024
CompanyDrug

Amgen’s Lumakras Faces Full Approval Delay as FDA Requests New Study

October 30, 2024
Policy / Regulatory

China’s NMPA Proposes Enhanced IT and Visualization Requirements for Blood Product GMP

October 30, 2024
CompanyMedical Device

Fresenius Medical Care Expands Dialysis Solutions in China with 6008 CARESystem Launch

October 30, 2024
Policy / Regulatory

China Charts Course for Advanced Disease Prevention and Control System by 2030

October 30, 2024
CompanyDeals

Innovent Biologics Partners with Sanegene Bio USA to Develop Hypertension Drug

October 30, 2024
CompanyDrug

Guangdong Zhongsheng Pharmaceutical’s ZSP1273 for Influenza A Accepted for Review by NMPA

October 30, 2024
CompanyDrug

Konruns Pharmaceutical Receives NMPA Go-Ahead for KC1036 Esophageal Cancer Study

December 28, 2024
CompanyDeals

Jianzhijia Health-Chain to Purchase Local Drug Retailer for $23.5 Million

October 30, 2024
1 2 3 4 5 … 21 22
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up